WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007088051) MODULATION OF MDL-1 ACTIVITY FOR TREATMENT OF INFLAMMATORY DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/088051    International Application No.:    PCT/EP2007/000862
Publication Date: 09.08.2007 International Filing Date: 26.01.2007
Chapter 2 Demand Filed:    25.10.2007    
IPC:
C07K 14/705 (2006.01)
Applicants: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT [DE/DE]; Müllerstrasse 178, 13353 Berlin (DE) (For All Designated States Except US).
FAULDS, Daryl [US/US]; (US) (For US Only).
FIORUCCI, Stefano [IT/IT]; (IT) (For US Only).
JIANG, Ping [US/US]; (US) (For US Only).
LIU, Yi [US/US]; (US) (For US Only).
PARKINSON, John [GB/US]; (US) (For US Only)
Inventors: FAULDS, Daryl; (US).
FIORUCCI, Stefano; (IT).
JIANG, Ping; (US).
LIU, Yi; (US).
PARKINSON, John; (US)
Priority Data:
60/764,124 31.01.2006 US
Title (EN) MODULATION OF MDL-1 ACTIVITY FOR TREATMENT OF INFLAMMATORY DISEASE
(FR) MODULATION DE L'ACTIVITE MDL-1 POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
Abstract: front page image
(EN)The present invention provides compositions and methods that modulate MDL-1 activity in a cell, in vivo or in vitro. In particular, the present invention provides methods for treatment of inflammatory diseases using synthetic or recombinant compositions that modulate MDL-1 activity in a mammalian cell, in vivo or invitro. More particularly, the present invention provides protein compositions useful for the treatment of diseases having an inflammatory process mediated by MDL-1.
(FR)La présente invention concerne des compositions et des procédés qui modulent l'activité MDL-1 dans une cellule, in vivo ou in vitro. L'invention concerne en particulier des procédés de traitement de maladies inflammatoires à l'aide de compositions synthétiques ou recombinantes qui modulent l'activité MDL-1 dans une cellule mammalienne, in vivo ou in vitro. Plus particulièrement, la présente invention concerne des compositions protéiniques utilisables pour le traitement de maladies dans lesquelles un processus inflammatoire est induit par MDL-1.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)